Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry F Chambers

Showing results (121-130 of 189) with videos related to

Pageof 19
Sort By:
Antimicrobial Agents and Chemotherapy|August 23, 2017
Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureusYuki Katayama, Takuya Azechi, Motoyasu Miyazaki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2009
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxicSara E Cosgrove, Gloria A Vigliani, Vance G Fowler, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2024
Sensitizing methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) to cefuroxime: the synergic effect of bicarbonate and the wall teichoic acid inhibitor ticlopidineSelvi C Ersoy, Richard A Proctor, Warren E Rose, et al.
Plos One|September 13, 2008
Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesisBinh An Diep, Amy M Palazzolo-Ballance, Pierre Tattevin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2024
Participant Diversity in United States Randomized Controlled Trials of Antibacterials for Staphylococcus aureus Infections, 2000-2021Jiye Kwon, William Pelletiers, Jessica Galloway Peña, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2014
Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of AmericaDennis L Stevens, Alan L Bisno, Henry F Chambers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2015
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)Scott R Evans, Daniel Rubin, Dean Follmann, et al.
Plos One|April 29, 2011
Global changes in Staphylococcus aureus gene expression in human bloodNatalia Malachowa, Adeline R Whitney, Scott D Kobayashi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2014
Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of AmericaDennis L Stevens, Alan L Bisno, Henry F Chambers, et al.
Plos One|November 7, 2009
Genetic diversity of arginine catabolic mobile element in Staphylococcus epidermidisMaria Miragaia, Herminia de Lencastre, Francoise Perdreau-Remington, et al.
Pageof 19

Showing results (121-130 of 189) with videos related to

Sort By:
Pageof 19
Antimicrobial Agents and Chemotherapy|August 23, 2017
Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureusYuki Katayama, Takuya Azechi, Motoyasu Miyazaki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2009
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxicSara E Cosgrove, Gloria A Vigliani, Vance G Fowler, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2024
Sensitizing methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) to cefuroxime: the synergic effect of bicarbonate and the wall teichoic acid inhibitor ticlopidineSelvi C Ersoy, Richard A Proctor, Warren E Rose, et al.
Plos One|September 13, 2008
Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesisBinh An Diep, Amy M Palazzolo-Ballance, Pierre Tattevin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2024
Participant Diversity in United States Randomized Controlled Trials of Antibacterials for Staphylococcus aureus Infections, 2000-2021Jiye Kwon, William Pelletiers, Jessica Galloway Peña, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2014
Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of AmericaDennis L Stevens, Alan L Bisno, Henry F Chambers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2015
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)Scott R Evans, Daniel Rubin, Dean Follmann, et al.
Plos One|April 29, 2011
Global changes in Staphylococcus aureus gene expression in human bloodNatalia Malachowa, Adeline R Whitney, Scott D Kobayashi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2014
Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of AmericaDennis L Stevens, Alan L Bisno, Henry F Chambers, et al.
Plos One|November 7, 2009
Genetic diversity of arginine catabolic mobile element in Staphylococcus epidermidisMaria Miragaia, Herminia de Lencastre, Francoise Perdreau-Remington, et al.
Pageof 19